Metformin regresses left ventricular hypertrophy in normotensive patients with coronary artery disease without type 2 diabetes mellitus - The MET-REMODEL trialM
University of Dundee, Dundee (United Kingdom of Great Britain & Northern Ireland)
1
presentation
0
follower
5
more
presentations
in this session
Association between insulin resistance and coronary plaque vulnerability in patients with acute coronary syndromes: insights from optical coherence tomography
Impact of statin treatment on the prevalence of lesion vulnerability and instability features in patients with diabetes mellitus - Insights from the COMBINE (FFR-OCT) Study
Impact of diabetes on 5-year clinical outcomes in stable coronary artery disease, across multiple geographical regions and ethnicities. Insights from the CLARIFY registry
Impact of chronic kidney disease on diabetic patients with stable coronary disease undergoing surgery, angioplasty or medical treatment in a ten-year follow-up.